A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma
Status:
Recruiting
Trial end date:
2023-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the role of 4-aminopyridine (4-AP) on the course of
recovery after peripheral nerve traction and/or crush injury. The investigational treatment
will be used to test the hypothesis that 4-aminopyridine speeds the often slow and
unpredictable recovery after peripheral nerve traction and/or crush injuries.